Abstract Library
Welcome to the open-access search for all ENETS abstracts presented at the Annual ENETS Conferences.
Everyone can browse the library to find basic information on abstracts. To get full access to each entry, you will be asked to log in to your myENETS account.
ENETS Abstract Search
Introduction: There remains no global consensus on the optimal management of bone metastases in patients with neuroendocrine neoplasms (BM-NEN).
Conference: 18th Annual ENETS Concerence (2021)
Presenting Author:
Authors: García-Torralba E, Lim K, Barriuso J, McNamara M, Hubner R,
Keywords: bone metastases, neuroendocrine neoplasm, skeletal-related events, bisphosphonates, radiotherapy, guidelines,
Introduction: The incidence and risk factors for everolimus-induced pneumonitis (EiP) have been poorly studied in patients (pts) with neuroendocrine neoplasms (NEN) outside of clinical trials.
Conference: 17th Annual ENETSConcerence (2020)
Presenting Author: Taboada R
Authors: Taboada R, Riechelmann R, Mauro C, Barros M, Hubner R,
Keywords: neuroendocrine, everolimus, pneumonitis,
Introduction: Platinum-etoposide (PE) chemotherapy (CH) is a globally established combination for EP-G3-NEC; the optimal schedule has not been established.
Conference: 15th Annual ENETSConcerence (2018)
Presenting Author: Lamarca A
Authors: Lamarca A, Frizziero M, Barriuso J, McNamara M, Hubner R,
Keywords: high grade, neuroendocrine, survey, chemotherapy, platinum, etoposide,
Introduction: Prognostic markers for risk-stratification of GI-NECs are lacking.
Conference: 13th Annual ENETSConcerence (2016)
Presenting Author: Lamarca A
Authors: Lamarca A, Barriuso J, McNamara M, Hubner R, Valle J,
Keywords: NEC, score, overall survival, high grade, prognostic,
Introduction: Capecitabine-temozolomide (CAPTEM) is a treatment option in patients (pts) with neuroendocrine tumours. Although efficacy data has been reported, no detailed safety information exists.
Conference: 13th Annual ENETSConcerence (2016)
Presenting Author: Papaxoinis G
Authors: Papaxoinis G, McCallum L, Nasralla M, Hubner R, McNamara M,
Keywords: capecitabine, temozolomide, NET,